Ison CA, Fifer H, Gwynn S, Horner P, Muir P, Nicholls J, Radcliffe K, Ross JDC, Taylor-Robinson D and White J. Highlighting the clinical need for diagnosing Mycoplasma genitalium infection. International Journal of STD & AIDS 2018;29:680-6. https://doi.org/10.1177/0956462417753527.
Ross JDC, Harding J and Duley L et al, on behalf of the G-TOG Collaborative Group. A randomised controlled trial to compare the clinical effectiveness, cost effectiveness and safety of gentamicin and ceftriaxone in the treatment of gonorrhoea (The G-TOG Trial). NIHR Health Technology Assessment Journal (in press).
Thorley N and Ross JDC. Intravaginal boric acid – is it an alternative therapeutic option for vaginal trichomoniasis? Sexually Transmitted Infections 2018 DOI: 10.1136/sextrans-2017-053343.
Hayward RS, Harding J, Molloy R, Land L, Longcroft-Neal K, Moore D and Ross JDC. Adverse Effects of a Single Dose of Gentamicin in Adults: A Systematic Review. British Journal of Clinical Pharmacology 2017 DOI:10.1111/bcp.13439
Savaris RF, Fuhrich DG, Duarte RV, Franik S and Ross J. Antibiotic therapy for pelvic inflammatory disease. Cochrane Database of Systematic Reviews 2017, Issue 4. Art. No: CD010285. DOI: 10.1002/14651858.CD010285.pub2.
Achhra A, Mocroft A, Ross M, Ryom-Nielson L, Avihingsanon A, Bakowska E, Belloso W, Clarke A, Furre H, Lucas GM, Ristola M, Rassool M, Ross J, Somboonwit C and Wyatt C. Impact of early versus deferred antiretroviral therapy on estimated glomerular filtration rate in HIV-positive individuals in the START randomised study. International Journal of Antimicrobial Agents 2017;50(3):453-460.
Ng A and Ross J. Trichomonas vaginalis infection: how significant is it in men presenting with recurrent or persistent symptoms of urethritis? International Journal of STD & AIDS 2016;27:63-65.
Town K, Obi C, Quaye N, Chisholm S, Hughes G , Livermore DM, Bignell C, Eastick K, Johnson A, Paul J, Robinson A and Ross J et al. Drifting towards ceftriaxone treatment failure in gonorrhoea: risk factor analysis of data from the Gonococcal Resistance to Antimicrobials Surveillance Programme in England and Wales. Sexually Transmitted Infections 2016 doi: 10.1136/sextrans-2016-052583.
Hathorn E, Ng A, Page M, Hodson J, Quinn N, Gaydos C and Ross JDC. A service evaluation of the Gen Probe APTIMA nucleic acid amplification test for Trichomonas Vaginalis: should it change whom we screen for infection? Sexually Transmitted Infections 2015;91(2):81-86.
Fernando KA, Flew SJ, Fowle T, Caley M, Phattey J, Harding J and Ross JDC. Detecting re-infection in patients after an initial diagnosis of gonorrhoea: is routine recall for re-screening useful? International Journal of STD & AIDS 2015;26:640-647.